Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_assertion type Assertion NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_head.
- NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_assertion description "[Our results show that gene expression profile differences in the PI3K-AKT signaling pathway identify two subgroups of high-grade endometrial carcinomas with different molecular alterations (PI3K-AKT pathway vs p53 alterations) that may have distinct roles in endometrial carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_provenance.
- NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_assertion evidence source_evidence_literature NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_provenance.
- NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_assertion SIO_000772 20173732 NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_provenance.
- NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_assertion wasDerivedFrom befree-2016 NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_provenance.
- NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_assertion wasGeneratedBy ECO_0000203 NP795025.RAUBeAn9FYu0sU5wL-Q88M7NKvGPrUVgMaVNJHcOhx1rM130_provenance.